Date of Award


Document Type


Degree Name

Master of Physician Assistant Studies


Physician Assistant Education

First Advisor

Mark Christiansen


Type 2 diabetes is a disease plaguing the American population, bringing along with it a number of complications. With millions of dollars spent annually to care for diabetic patients and the complications of diabetes, much remains to be known regarding newer medications and the effects of those complications. Two sodium glucose co-transporter 2 inhibitors, canagliflozin and empagliflozin, and one glucagon-like peptide-1 receptor agonist, liraglutide, have proven cardiovascular benefit; however, their use in combination with metformin has not been well studied when compared to metformin and sulfonylurea therapy. While there are studies underway evaluating such outcomes, a critical review of current literature has revealed a lack of research to aid in the decision-making process of type 2 diabetes treatment.

Lucas_Presentation Slides.pptx (730 kB)
Click here to download Presentation Slides

Lucas_Presentation Slides.pptx (730 kB)
Click here to download Presentation Slides



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.